Citadel Advisors »

G1 Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $408k 134k 3.05
2023-09-30 $311k 216k 1.44
2023-06-30 $472k 189k 2.49
2023-03-31 $471k 176k 2.68
2022-12-31 $2.0M 367k 5.43
2022-06-30 $1.7M 343k 4.94
2022-03-31 $2.5M 332k 7.60
2021-12-31 $3.4M 334k 10.21
2021-09-30 $1.1M 85k 13.41
2021-06-30 $3.2M 148k 21.94
2021-03-31 $4.4M 181k 24.07
2020-12-31 $6.1M 337k 17.98
2020-09-30 $4.1M 358k 11.55
2020-06-30 $1.9M 80k 24.26
2020-03-31 $1.4M 125k 11.06
2019-12-31 $3.3M 129k 25.81
2019-09-30 $400k 18k 22.81
2019-06-30 $708k 23k 30.65
2019-03-31 $4.6M 279k 16.61
2018-12-31 $3.3M 172k 19.15
2018-09-30 $243k 4.6k 52.36
2018-03-31 $308k 8.3k 37.00